Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 881–890 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 881
- Medicine slug
- lithium-carbonate
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 54
- Source count
- 24
- Agreement rate
- 1
- Recorded readings
18 to 36 hours
- Numeric value
- 18
- Unit
- hours
- Source records
- 24
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 24 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b81eabc-5c5a-4b63-88d4-3f13b45a683e (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3284649-ed4c-4096-987b-4ac16b8278f2 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5102eb69-4872-53fb-e063-6394a90a8275 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05312159-3d8a-45e0-99cb-b83a7b200cd3 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bfececc8-b2ab-47d1-b126-1c6592bc9c26 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:049902a9-3af1-4863-994e-15f36e7a9793 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c84cce95-cfcb-4426-aac6-d2f48f946ada (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:204d94de-83e4-400e-bd6b-70b49813802c (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:63b3790f-a9b5-47f4-bae1-ddf8b43c13c1 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c320bff-b4d5-42f2-b2b5-238564fe9589 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04518b80-7563-4544-bf05-04f286223faa (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b074ca9f-66b2-4e83-b67d-cb317b46411b (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d20ed2aa-aa56-4709-9e7a-9243c71465c9 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ca2b977-b94c-4232-9b7e-835db97c9544 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:203386e3-718f-7c84-e063-6394a90aed34 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:57faf0b0-4380-4bbf-8de7-c3f9d74fc410 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0e6b0a2d-b79c-44d8-b785-5267df9e8f72 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7dc9c6d2-6d9a-49e4-a8ab-437b0ed5f84e (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:582697c1-063f-366f-e063-6294a90a8d1b (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16ebe1f9-501d-468b-a37d-f6a46f8f32d1 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:803eab29-0d0a-4df0-b504-bcd85ec01ead (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c4973d87-d014-42f4-ba13-ae628ca1a451 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01c4facd-ed79-4078-ba33-2044de372d0f (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a62d5ae-a4a3-4b10-8281-feba134bbe3a (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
The elimination half-life of lithium is approximately 18 to 36 hours.
Projected row 882
- Medicine slug
- lithium-carbonate
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 54
- Source count
- 24
- Agreement rate
- 1
- Recorded readings
0.25 to 3 hours
- Numeric value
- 0.25
- Unit
- hours
- Source records
- 24
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 24 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b81eabc-5c5a-4b63-88d4-3f13b45a683e (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3284649-ed4c-4096-987b-4ac16b8278f2 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5102eb69-4872-53fb-e063-6394a90a8275 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05312159-3d8a-45e0-99cb-b83a7b200cd3 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bfececc8-b2ab-47d1-b126-1c6592bc9c26 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:049902a9-3af1-4863-994e-15f36e7a9793 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c84cce95-cfcb-4426-aac6-d2f48f946ada (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:204d94de-83e4-400e-bd6b-70b49813802c (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:63b3790f-a9b5-47f4-bae1-ddf8b43c13c1 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c320bff-b4d5-42f2-b2b5-238564fe9589 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04518b80-7563-4544-bf05-04f286223faa (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b074ca9f-66b2-4e83-b67d-cb317b46411b (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d20ed2aa-aa56-4709-9e7a-9243c71465c9 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ca2b977-b94c-4232-9b7e-835db97c9544 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:203386e3-718f-7c84-e063-6394a90aed34 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:57faf0b0-4380-4bbf-8de7-c3f9d74fc410 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0e6b0a2d-b79c-44d8-b785-5267df9e8f72 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7dc9c6d2-6d9a-49e4-a8ab-437b0ed5f84e (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:582697c1-063f-366f-e063-6294a90a8d1b (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16ebe1f9-501d-468b-a37d-f6a46f8f32d1 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:803eab29-0d0a-4df0-b504-bcd85ec01ead (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c4973d87-d014-42f4-ba13-ae628ca1a451 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01c4facd-ed79-4078-ba33-2044de372d0f (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a62d5ae-a4a3-4b10-8281-feba134bbe3a (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
Peak serum concentrations (T max ) occur 0.25 to 3 hours after oral administration of immediate release preparations and 2 to 6 hours after sustained-release preparations.
Projected row 883
- Medicine slug
- lithium-carbonate
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 54
- Source count
- 24
- Agreement rate
- 1
- Recorded readings
0.7 to 1 L/kg
- Numeric value
- 0.7
- Unit
- L/kg
- Source records
- 24
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 24 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b81eabc-5c5a-4b63-88d4-3f13b45a683e (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3284649-ed4c-4096-987b-4ac16b8278f2 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5102eb69-4872-53fb-e063-6394a90a8275 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05312159-3d8a-45e0-99cb-b83a7b200cd3 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bfececc8-b2ab-47d1-b126-1c6592bc9c26 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:049902a9-3af1-4863-994e-15f36e7a9793 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c84cce95-cfcb-4426-aac6-d2f48f946ada (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:204d94de-83e4-400e-bd6b-70b49813802c (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:63b3790f-a9b5-47f4-bae1-ddf8b43c13c1 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c320bff-b4d5-42f2-b2b5-238564fe9589 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04518b80-7563-4544-bf05-04f286223faa (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b074ca9f-66b2-4e83-b67d-cb317b46411b (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d20ed2aa-aa56-4709-9e7a-9243c71465c9 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4ca2b977-b94c-4232-9b7e-835db97c9544 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:203386e3-718f-7c84-e063-6394a90aed34 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:57faf0b0-4380-4bbf-8de7-c3f9d74fc410 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0e6b0a2d-b79c-44d8-b785-5267df9e8f72 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7dc9c6d2-6d9a-49e4-a8ab-437b0ed5f84e (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:582697c1-063f-366f-e063-6294a90a8d1b (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:16ebe1f9-501d-468b-a37d-f6a46f8f32d1 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:803eab29-0d0a-4df0-b504-bcd85ec01ead (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c4973d87-d014-42f4-ba13-ae628ca1a451 (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:01c4facd-ed79-4078-ba33-2044de372d0f (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a62d5ae-a4a3-4b10-8281-feba134bbe3a (opens source in a new tab)
Lithium Carbonate label
Version not recorded · Effective date not recorded
After equilibrium, the apparent volume of distribution is 0.7 to 1 L/kg.
Projected row 884
- Medicine slug
- lofexidine
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 8
- Source count
- 8
- Agreement rate
- 1
- Recorded readings
30%
- Numeric value
- 30
- Unit
- %
- Source records
- 8
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 8 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b748f308-ba71-4fd9-84ec-ec7e0f210885 (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Elimination Metabolism From absolute bioavailability results, approximately 30% of the administered LUCEMYRA dose is converted to inactive metabolites during the first pass effect associated with drug absorption from the gut.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:77367dfa-434f-4d61-95fe-f0f1628457d1 (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Elimination Metabolism From absolute bioavailability results, approximately 30% of the administered lofexidine dose is converted to inactive metabolites during the first pass effect associated with drug absorption from the gut.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a848cc2-4dda-40d9-8b01-d789fe8981ed (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Elimination Metabolism From absolute bioavailability results, approximately 30% of the administered LUCEMYRA dose is converted to inactive metabolites during the first pass effect associated with drug absorption from the gut.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2dcc8288-adbe-45c3-b7bd-4d274001332d (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Elimination Metabolism From absolute bioavailability results, approximately 30% of the administered Lofexidine tablets dose is converted to inactive metabolites during the first pass effect associated with drug absorption from the gut.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ce4488e2-842c-45ba-aca7-075a900e2a1c (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Elimination Metabolism From absolute bioavailability results, approximately 30% of the administered lofexidine tablet dose is converted to inactive metabolites during the first pass effect associated with drug absorption from the gut.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:19b5c932-af2d-4a0b-ac4a-ba06c53c3219 (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Elimination Metabolism From absolute bioavailability results, approximately 30% of the administered lofexidine dose is converted to inactive metabolites during the first pass effect associated with drug absorption from the gut.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed7613f5-ac52-4108-afb7-d92c818d6e3c (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Elimination Metabolism From absolute bioavailability results, approximately 30% of the administered lofexidine tablet dose is converted to inactive metabolites during the first pass effect associated with drug absorption from the gut.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:335e26bf-b236-46d6-81cf-2879e5f3b1d9 (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Elimination Metabolism From absolute bioavailability results, approximately 30% of the administered lofexidine dose is converted to inactive metabolites during the first pass effect associated with drug absorption from the gut.
Projected row 885
- Medicine slug
- lofexidine
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 8
- Source count
- 8
- Agreement rate
- 1
- Recorded readings
12 hours
- Numeric value
- 12
- Unit
- hours
- Source records
- 8
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 8 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b748f308-ba71-4fd9-84ec-ec7e0f210885 (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Excretion The elimination half-life is approximately 12 hours and mean clearance is 17.6 L/h following an IV infusion.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:77367dfa-434f-4d61-95fe-f0f1628457d1 (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Excretion The elimination half-life is approximately 12 hours and mean clearance is 17.6 L/h following an IV infusion.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a848cc2-4dda-40d9-8b01-d789fe8981ed (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Excretion The elimination half-life is approximately 12 hours and mean clearance is 17.6 L/h following an IV infusion.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2dcc8288-adbe-45c3-b7bd-4d274001332d (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Excretion The elimination half-life is approximately 12 hours and mean clearance is 17.6 L/h following an IV infusion.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ce4488e2-842c-45ba-aca7-075a900e2a1c (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Excretion The elimination half-life is approximately 12 hours and mean clearance is 17.6 L/h following an IV infusion.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:19b5c932-af2d-4a0b-ac4a-ba06c53c3219 (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Excretion The elimination half-life is approximately 12 hours and mean clearance is 17.6 L/h following an IV infusion.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed7613f5-ac52-4108-afb7-d92c818d6e3c (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Excretion The elimination half-life is approximately 12 hours and mean clearance is 17.6 L/h following an IV infusion.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:335e26bf-b236-46d6-81cf-2879e5f3b1d9 (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Excretion The elimination half-life is approximately 12 hours and mean clearance is 17.6 L/h following an IV infusion.
Projected row 886
- Medicine slug
- lofexidine
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 8
- Source count
- 8
- Agreement rate
- 1
- Recorded readings
55%
- Numeric value
- 55
- Unit
- %
- Source records
- 8
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 8 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b748f308-ba71-4fd9-84ec-ec7e0f210885 (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
LUCEMYRA protein binding is approximately 55%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:77367dfa-434f-4d61-95fe-f0f1628457d1 (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Lofexidine protein binding is approximately 55%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a848cc2-4dda-40d9-8b01-d789fe8981ed (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
LUCEMYRA protein binding is approximately 55%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2dcc8288-adbe-45c3-b7bd-4d274001332d (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Lofexidine tablets protein binding is approximately 55%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ce4488e2-842c-45ba-aca7-075a900e2a1c (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Lofexidine protein binding is approximately 55%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:19b5c932-af2d-4a0b-ac4a-ba06c53c3219 (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Lofexidine protein binding is approximately 55%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed7613f5-ac52-4108-afb7-d92c818d6e3c (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Lofexidine tablet protein binding is approximately 55%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:335e26bf-b236-46d6-81cf-2879e5f3b1d9 (opens source in a new tab)
Lofexidine label
Version not recorded · Effective date not recorded
Lofexidine protein binding is approximately 55%.
Projected row 887
- Medicine slug
- lomitapide
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
7%
- Numeric value
- 7
- Unit
- %
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e4c45bb5-15f4-437e-ab98-a649b3676d14 (opens source in a new tab)
Lomitapide label
Version not recorded · Effective date not recorded
The absolute bioavailability of lomitapide is approximately 7%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61a0be9d-ee58-43e0-b5cb-141011835081 (opens source in a new tab)
Lomitapide label
Version not recorded · Effective date not recorded
Absorption The absolute bioavailability of lomitapide is approximately 7%.
Projected row 888
- Medicine slug
- lomitapide
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
39.7 hours
- Numeric value
- 39.7
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e4c45bb5-15f4-437e-ab98-a649b3676d14 (opens source in a new tab)
Lomitapide label
Version not recorded · Effective date not recorded
The mean lomitapide terminal half-life is 39.7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61a0be9d-ee58-43e0-b5cb-141011835081 (opens source in a new tab)
Lomitapide label
Version not recorded · Effective date not recorded
The mean lomitapide terminal half-life is 39.7 hours.
Projected row 889
- Medicine slug
- lomitapide
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
985-1292 liters
- Numeric value
- 985
- Unit
- L
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e4c45bb5-15f4-437e-ab98-a649b3676d14 (opens source in a new tab)
Lomitapide label
Version not recorded · Effective date not recorded
Distribution The mean lomitapide volume of distribution at steady state is 985-1292 liters.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61a0be9d-ee58-43e0-b5cb-141011835081 (opens source in a new tab)
Lomitapide label
Version not recorded · Effective date not recorded
Distribution The mean lomitapide volume of distribution at steady state is 985 to 1292 liters.
Projected row 890
- Medicine slug
- lomustine
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 4
- Source count
- 4
- Agreement rate
- 1
- Recorded readings
16 hours
- Numeric value
- 16
- Unit
- hours
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:916dfac8-da11-40e4-9e44-a909e29a6b5f (opens source in a new tab)
Lomustine label
Version not recorded · Effective date not recorded
Elimination The serum half-life of lomustine metabolites ranges from 16 hours to 48 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f77526b-4c40-409c-82ea-d0f934d89cc2 (opens source in a new tab)
Lomustine label
Version not recorded · Effective date not recorded
Elimination The serum half-life of lomustine metabolites ranges from 16 hours to 48 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c3637fc-4499-4331-a3c4-6969fc86704e (opens source in a new tab)
Lomustine label
Version not recorded · Effective date not recorded
Elimination The serum half-life of lomustine metabolites ranges from 16 hours to 48 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3529fe2f-3c23-4862-bb20-b48026957082 (opens source in a new tab)
Lomustine label
Version not recorded · Effective date not recorded
Elimination The serum half-life of lomustine metabolites ranges from 16 hours to 48 hours.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=880Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.